Announcement PDF Appendix 2A - Application for quotation of securities Announcement Summary Entity name RECCE PHARMACEUTICALS LTD Announcement Type New announcement Date of this announcement Tuesday April 16, 2024 The +securities to be quoted are: Other Please refer to the response to Q2.3d for further information about the type of securities to be quoted and the circumstances of the issue. The Company has issued 250,000 fully paid ordinary shares to a consultant for services provided to the Company over a one year term in lieu of a cash payment. Total number of +securities to be quoted ASX +security code Security description RCE ORDINARY FULLY PAID Number of +securities to be quoted Issue date 250,000 16/04/2024 Refer to next page for full details of the announcement Appendix 2A - Application for quotation of securities 1/6 Appendix 2A - Application for quotation of securities Part 1 - Entity and announcement details 1.1 Name of entity RECCE PHARMACEUTICALS LTD We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules. 1.2 Registered number type Registration number ACN 124849065 1.3 ASX issuer code RCE 1.4 The announcement is New announcement 1.5 Date of this announcement 16/4/2024 Appendix 2A - Application for quotation of securities 2/6 Appendix 2A - Application for quotation of securities Part 2 - Type of Issue 2.1 The +securities to be quoted are: Other Please refer to the response to Q2.3d for further information about the type of securities to be quoted and the circumstances of the issue. 2.2 The +class of +securities to be quoted is: Additional +securities in a class that is already quoted on ASX ("existing class") 2.3c Have these +securities been offered under a +disclosure document or +PDS? No 2.3d Please provide any further information needed to understand the circumstances in which you are applying to have these +securities quoted on ASX, including why the issue of the +securities has not been previously announced to the market in an Appendix 3B The Company has issued 250,000 fully paid ordinary shares to a consultant for services provided to the Company over a one year term in lieu of a cash payment. 2.4 Any on-sale of the +securities to be quoted within 12 months of their date of issue will comply with the secondary sale provisions in sections 707(3) and 1012C(6) of the Corporations Act by virtue of: The publication of a cleansing notice under section 708A(5), 708AA(2)(f), 1012DA(5) or 1012DAA(2)(f) Appendix 2A - Application for quotation of securities 3/6 Appendix 2A - Application for quotation of securities Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B Additional +securities to be quoted in an existing class ASX +security code and description RCE : ORDINARY FULLY PAID Issue date 16/4/2024 Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class? Yes Issue details Number of +securities to be quoted 250,000 Are the +securities being issued for a cash consideration? No Please describe the consideration being provided for the +securities The shares are being issued to pay for services rendered. The estimated value of the consideration per share is based on the closing price of RCE shares on 15 April 2024 being $0.495 per share. Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted 0.495000 Any other information the entity wishes to provide about the +securities to be quoted The purpose(s) for which the entity is issuing the securities To pay for services rendered Please provide additional details The shares are being issued for the provision of services performed including market analysis and research, strategic planning and advisory, investor relations support and stakeholder engagement over a one year term in lieu of a cash payment. Appendix 2A - Application for quotation of securities 4/6 Appendix 2A - Application for quotation of securities Part 4 - Issued capital following quotation Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise: The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing. 4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application) ASX +security code and description Total number of +securities on issue RCE : ORDINARY FULLY PAID 203,951,863 4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX) ASX +security code and description Total number of +securities on issue RCEAH : PERFORMANCE SHARES 8,754,423 RCEAW : OPTION EXPIRING 11-FEB-2027 EX $1.56 435,000 RCEAU : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES 1,125,000 RCEAN : OPTION EXPIRING 22-FEB-2026 EX $1.56 8,415,000 Appendix 2A - Application for quotation of securities 5/6 Appendix 2A - Application for quotation of securities Part 5 - Other Listing Rule requirements 5.1 Are the +securities being issued under an exception in Listing Rule 7.2 and therefore the issue does not need any security holder approval under Listing Rule 7.1? No 5.2 Has the entity obtained, or is it obtaining, +security holder approval for the issue under listing rule 7.1? No 5.2b Are any of the +securities being issued without +security holder approval using the entity's 15% placement capacity under listing rule 7.1? Yes 5.2b.1 How many +securities are being issued without +security holder approval using the entity's 15% placement capacity under listing rule 7.1? 250,000 5.2c Are any of the +securities being issued without +security holder approval using the entity's additional 10% placement capacity under listing rule 7.1A (if applicable)? No Appendix 2A - Application for quotation of securities 6/6